Discovery of YYSW001: A Highly Selective, Orally Bioavailable JAK1 Inhibitor Achieving Efficacy under a Moderate-Inhibition Strategy with Improved Preclinical Tolerability
用户6X7Ch8WUQ_gI
1小时前
4
10
求助中
帖子自动结束时间: 2026-03-26 20:43:28
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性，不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1021/acs.jmedchem.5c03183
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c03183
其他信息:
出版社: American Chemical Society (ACS)
作者: Kaiyong Hu; Yezhi Wang; Pengfei Xu; Tian Jing; Xinying Cheng; Pei Shen; Baoxin Wang; Kang Fu; Min Zhang; Mingjing Gao; Zhiyu Li; Jubo Wang; Zhixia Qiu; Jinlei Bian
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c03183
